A randomized, double-blind, placebo- and active-controlled, multiple ascending-dose study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of mirogabalin in healthy elderly subjects

Trial Profile

A randomized, double-blind, placebo- and active-controlled, multiple ascending-dose study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of mirogabalin in healthy elderly subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Feb 2016

At a glance

  • Drugs Mirogabalin (Primary) ; Pregabalin
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 02 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top